Patents Assigned to A.P. Group, Inc.
  • Antitumor drugs and methods
    Patent number: 6747011
    Abstract: Derivatives of apoptolidin, including skeletal homologues, are potent and selective apoptosis-inducing agents which, unlike apoptolidin, do not undergo isomerization under physiological conditions. These compounds exhibit antitumor properties, often superior to those of apoptolidin, and as such can be used in the treatment of cancer and other hyperproliferative disorders.
    Type: Grant
    Filed: June 4, 2003
    Date of Patent: June 8, 2004
    Assignee: A.P. Group, Inc.
    Inventor: Jennifer H. Zhang
  • Cholesterol and triglyceride-modulating drugs and methods
    Patent number: 6683104
    Abstract: Urea compounds disclosed herein increase HDL-C levels and as such can be used in prevention and treatment of atherosclerosis, myocardial infarction and related conditions such as peripheral vascular disease and ischemic stroke hypoalphalipoproteinemia.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: January 27, 2004
    Assignee: A.P. Group, Inc.
    Inventor: Jennifer H. Zhang